NUVL.NASDAQNuvalent, INC

Form 4: Nuvalent Director Andrew Hack Reports Stock and Option Awards

Sentiment:

SEC Form 4 Filing


Director Andrew Hack reports acquisition of restricted stock units and stock options in Nuvalent, Inc.

Summary

  • On June 12, 2024, Andrew Hack, a director of Nuvalent, Inc., reported the acquisition of 2,499 Class A Common Stock Restricted Stock Units (RSUs) and stock options for 3,789 shares.
  • The RSUs will vest on the earlier of June 12, 2025, or the date of the Issuer's next annual meeting of stockholders, subject to continued service.
  • The stock options, with an exercise price of $80.03, will also vest on the earlier of June 12, 2025, or the date of the Issuer's next annual meeting of stockholders, subject to continued service.
  • Hack also indirectly owns 2,697,267 shares of Class A Common Stock through Bain Capital Life Sciences Entities but disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and alignment of director's interests with the company's performance. The director's acquisition of equity suggests confidence in the company's future.

Positives

  • The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
  • The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Future Outlook

The vesting of RSUs and stock options is contingent upon continued service to the Issuer, aligning the director's interests with the company's long-term success.

Industry Context

Stock options and RSU grants are common compensation practices in the biotech industry to incentivize and retain key personnel.

Comparison to Industry Standards

  • Equity grants to directors are a standard practice across the biotech industry.
  • Companies like Amgen, Gilead, and Biogen also use stock options and RSUs as part of their compensation packages for directors and executives.
  • The vesting schedules, typically tied to continued service, are also in line with industry norms.

Stakeholder Impact

  • The acquisition of equity by a director can positively influence shareholder confidence.
  • The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Key Dates

DateDescription
06/12/2024Date of transaction: acquisition of RSUs and stock options.
06/12/2025Vesting date for RSUs and stock options (or earlier if the next annual meeting of stockholders occurs before this date).
06/12/2034Expiration date for the stock options.
06/14/2024Date of signature for the SEC Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.